… , metabolism and respiratory diseases. AstraZeneca PLC (NASDAQ:AZN) has a … help it navigate upcoming patent expirations. By the end … first quarter of 2025, AstraZeneca PLC (NASDAQ:AZN) reported … total revenue by 2030. AstraZeneca PLC (NASDAQ:AZN) currently …

… Korean patients.  The decision, AstraZeneca said, “is not related … according to hospital specialists. AstraZeneca’s decision follows its … keep slashing prices after patent expiration, even if the … of torture,” he said. AstraZeneca, meanwhile, is pivoting to …

… boost after court affirms that AstraZeneca’s patent ‘did not make it … art. On appeal, AstraZeneca contended that its patent made a sufficient technical … court rejected AstraZeneca’s attempts to read into the patent a disclosure …

Cancer Astrazeneca AB has disclosed proteolysis targeting … . BioWorld Science Cancer Degradation inducer Patents

… growth. Major players include AstraZeneca and Pfizer, highlighting a … Market Trends Impact Analysis Patent Analysis Patent Filing Trend (by … Country) Patent Filing Trend (by Year … Players and Competition Synopsis AstraZeneca Procter & Gamble …

… confidence, challenging market uptake. Patent Expiry: Expiry of blockbuster … drug patents is leading to … moving toward an extended patent cliff, with several revenue … Medicines Eli Lilly Pfizer Astrazeneca Roche Boehringer Ingelheim Merck …

… with sector-specific listings for patents, trademarks and trade secrets. The portfolio … by Microsoft, Sanofi and AstraZeneca for patent work—has been fielding … knowledge include Murgitroyd senior European patent attorney Gabrielle Radault, whose …

… #39;buy' recommendation on AstraZeneca PLC (LSE:AZN), setting a … after a period dominated by patent expiries and pricing headwinds. … third quarter of 2025, AstraZeneca faces what UBS describes as … -return case leans on AstraZeneca’s reliable dividend and …

Gastrointestinal Astrazeneca AB has reported the identification … ), among others. BioWorld Science Gastrointestinal Patents

Gastrointestinal Astrazeneca AB has divulged 17β-hydroxysteroid … (hepatocellular carcinoma). BioWorld Science Gastrointestinal Patents